Source: Annual Congress 2001 - Noninvasive markers of airway inflammation, bronchoprovocation, or both?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Yemelyanov, G. Fedoseev, T. Trendeleva, A. Abulimity, O. Krasnoschekova, A. Lintsov (Saint-Petersburg, Russia). Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD. Eur Respir J 2001; 16: Suppl. 31, 1113

Member's Comments

No comment yet.

Related content which might interest you: The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008 N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005 A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibilityand stability Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001 Relationship between hydrogen peroxide levels in exhaled breath condensate and long term changes in small airway function of patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007 Increased concentration of hydrogen peroxide (H2O2) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Correlation of H2O2, pH and nitrite/nitrate in exhaled breath condensate and systemic inflammatory parameters during and after acute COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 349s Year: 2005 Variation of exhaled hydrogen peroxide in stable COPD patients and matched healthy persons over time Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate Source: Eur Respir J 2004; 23: 189-192 Year: 2004 Exercise increases the hydrogen peroxide release in exhaled breath condensate Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 The effect of inhaled corticosteroids on hydrogen peroxide exhalation in stable COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 Exhaled breath condensate: hydrogen peroxide Source: Eur Respir Monogr 2010; 49: 162-172 Year: 2010 Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Acute neutrophilic airway inflammation is associated with a decrease in pulmonary ascorbic acid concentration but not an elevation of exhaled hydrogen peroxide Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004 Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 506s Year: 2002 The airways are the main source of hydrogen peroxide in exhaled breath condensate Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010